RNAC vs UBER · P/E 2.1, rev $38.9M vs P/E 18, rev $52.02B
Cartesian Therapeutics Inc. (RNAC) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported RNAC revenue for 2024-12-31 was $38.9M. Net income was -$77.4M. Revenue was up 49.6% from 2023-12-31 to 2024-12-31. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
RNAC currently screens at market cap $290.9M and trailing P/E 2.1. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the RNAC and UBER stock pages for the full models.
Not investment advice.